Guangzhou Medical University
Clinical trials sponsored by Guangzhou Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New spinal fluid treatment targets deadly cancer spread Results expected Sep 2026 (estimated)
- Spinal fluid injection of Dual-Target antibody and chemotherapy shows promise for deadly cancer complication Results expected Sep 2026 (estimated)
- Spinal injection of dual immunotherapy plus chemotherapy targets cancer spread to brain lining Results expected Dec 2026 (estimated)
- New lung biopsy method aims for safer, more accurate diagnosis Results expected Dec 2026 (estimated)
- Robot combines detection, biopsy, and ablation for lung cancer in single session Results expected Dec 2026 (estimated)
-
New spinal fluid treatment targets deadly cancer spread
Disease control OngoingThis study tests a new treatment for leptomeningeal metastasis, a condition where cancer spreads to the lining of the brain and spinal cord. The treatment combines an immune checkpoint inhibitor (a drug that helps the immune system fight cancer) with pemetrexed (a chemotherapy dr…
Phase 1/2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Sep 21, 2026 22:00 UTC
-
Spinal fluid injection of Dual-Target antibody and chemotherapy shows promise for deadly cancer complication
Disease control OngoingThis phase I/II trial tests a combination of two drugs injected directly into the spinal fluid for people with leptomeningeal metastasis, a condition where cancer spreads to the membranes surrounding the brain and spinal cord. The drugs are a bispecific antibody (cadonilimab) tha…
Phase 1/2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Spinal injection of dual immunotherapy plus chemotherapy targets cancer spread to brain lining
Disease control OngoingThis phase I/II trial tests a combination of two drugs given directly into the spinal fluid for people with leptomeningeal metastasis, a condition where cancer spreads to the membranes covering the brain and spinal cord. The drugs are QL1706, a bispecific antibody that blocks two…
Phase 1/2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New combo targets KRAS lung cancer in patients who Can't have surgery
Disease control OngoingThis trial is testing a combination of the immunotherapy drug tislelizumab plus two chemotherapy drugs (albumin-bound paclitaxel and a platinum agent) in 30 people with a specific type of lung cancer called KRAS-mutant non-small cell lung cancer. The participants have advanced or…
Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
AI could revolutionize severe pneumonia diagnosis
Knowledge-focused OngoingThis study is testing whether an artificial intelligence model can more accurately diagnose the cause of severe pneumonia compared to traditional methods. Researchers will collect data from 1,000 ICU patients, including medical images, lab tests, and immune system information. Th…
Sponsor: Guangzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC